DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo


company name or ticker

Down 47%: Why the Market is Wrong About Celldex Stock

Celldex Therapeutics's epic decline begun once the company shut down CDX-1135, but are the losses warranted, or is the company now presenting great value?

bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape

bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?

10 Reasons Your Prescription Drug Prices Are So Painfully High

Research and development costs are only one piece of the puzzle. Here are nine additional reasons why your prescription drug costs are so painfully high.

Top Biotech Earnings Previews for the Week Ahead

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Why Salix Pharmaceuticals Is Doing Right by Investors

Why aren't investors celebrating Salix Pharmaceuticals's acquisition of Cosmo, and should they be?

3 Stocks Near 52-Week Highs Worth Selling

Are these three stocks sells or belles? You be the judge!

S&P 500 Movers: GRMN, AA

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

See More Articles...